Roundtable Discussion; The Future of Mineral Sands. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksVEC.L Share News (VEC)

  • There is currently no data for VEC

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

FTSE 250 movers: Zoopla helps keep market marginally in the black

Fri, 08th Jan 2016 15:11

(ShareCast News) - The FTSE 250 remained in the black by mid-afternoon, but only just with the market up 0.27 points (0.00%) to 16,792.49.Zoopla Property Group surged nearly 7% after Berenberg issued an analysis of the media sector and reiterated its 'buy' rating for the property classifieds website as well as its target price of 300p.The investment bank said the online classified model is extremely attractive, especially when it comes to property. "At a critical mass, of which Zoopla has reached, there is a certain dependency from househunters and therefore a necessity for agents to be members." While On The Market has recently entered the scene, Berenberg didn't believe it differentiate enough from Zoopla it and won't last long-term, saying the disruption from the new competitor is an overreaction. "That said, OTM should still be considered a disruptor to what is a solid structural growth and margin development story."Vectura Group wasn't too far behind after it announced it had made a big step forward in the development of two of its products on Friday, VR315 and VR506, with the completion of a US clinical trial and the disclosure of its US development partner.The firm described VR315 as a generic, inhaled combination therapy of fluticasone and salmeterol, delivered to asthma and chronic obstructive pulmonary disease sufferers using a proprietary dry powder inhaler and Vectura's formulation technology. It also confirmed that its partner in developing the VR315 programme, as well as the VR506 product, was Roxane Laboratories - a subsidiary of Boehringer Ingelheime based in Connecticut.Just Eat also rose as investors digested a broker note from Jefferies that upgraded the company's price target from 515p to 550p and reiterated its 'buy' rating.It said that it isn't entirely sure if the website statistics have been priced in yet, but an increase of the commission it takes on takeaway orders to 14% certainly isn't. "Our recent review of JE's TR network suggests that TR's new to the UK network are now being charged a 14% commission rate. JE last upped the UK rate from 11% to 12% in January 2014, we conclude two things. The UK rate steps up to 14% not 13% and that this happens in 2016."As some uncertainty remained about what would happen next in China, one of the world's biggest commodities consumers, miners and oil companies continued to lead the fallers by the end of the week.Chinese markets appeared to be in a less fidgety mood, given Beijing had suspended its new circuit-breaker rule which closed the markets twice this week. The Shanghai Composite Index finished up 1.97% at 3,186.41, a slight recovery from the 7% dive it took during the 30-minute trading day on Thursday. However oil prices were still sitting around $33 a barrel, driven down after Iran has banned imports from Saudi Arabia as the rift between the two nations escalated earlier this week. It came as Iran reportedly accused Saudi Arabia of intentionally launching an airstrike on its embassy in Yemeni capital Sanaa.These international events all had an impact on seven of the 10 biggest fallers. Tullow Oil also had its target price lowered by JP Morgan from 310p to 295p. FTSE 250 - RisersZoopla Property Group (WI) (ZPLA) 240.40p 6.84%Vectura Group (VEC) 188.50p 5.84%Elementis (ELM) 217.50p 4.92%Just Eat (JE.) 474.20p 3.65%Marston's (MARS) 164.40p 3.53%Auto Trader Group (AUTO) 440.30p 3.24%Card Factory (CARD) 351.40p 2.78%Betfair Group (BET) 3,977.00p 2.76%BBA Aviation (BBA) 178.60p 2.70%Poundland Group (PLND) 172.00p 2.50%FTSE 250 - FallersTullow Oil (TLW) 141.30p -5.80%Evraz (EVR) 63.70p -5.77%Vedanta Resources (VED) 227.10p -5.22%Jimmy Choo (CHOO) 121.10p -4.12%Wood Group (John) (WG.) 560.00p -3.53%Petrofac Ltd. (PFC) 715.50p -3.51%Ophir Energy (OPHR) 85.05p -3.46%Debenhams (DEB) 65.50p -3.25%Cairn Energy (CNE) 137.00p -3.18%Enterprise Inns (ETI) 104.50p -3.15%
More News
18 Dec 2020 08:12

Hikma rallies as it launches generic version of Glaxo asthma treatment

(Sharecast News) - Hikma Pharmaceuticals shares rallied after the company said it had received approval from the US Food and Drug Administration and launched its generic version of GlaxoSmithKline's asthma treatment, Advair Diskus.

Read more
17 Dec 2020 18:10

Hikma Pharmaceuticals Gets US FDA Approval For Generic Advair Diskus

Hikma Pharmaceuticals Gets US FDA Approval For Generic Advair Diskus

Read more
4 Dec 2020 13:05

IN BRIEF: Tissue Regenix Adds Former Vectura COO To Board

IN BRIEF: Tissue Regenix Adds Former Vectura COO To Board

Read more
30 Nov 2020 09:53

Vectura Inks Agreement To Support Kinaset Therapeutics For Asthma Drug

Vectura Inks Agreement To Support Kinaset Therapeutics For Asthma Drug

Read more
30 Nov 2020 08:06

Vectura signs asthma treatment deal with Kinaset

(Sharecast News) - Vectura has signed a global licence and development deal with Kinaset Therapeutics of the US for the development and commercialisation of the VR588 pan-JAK asthma treatment.

Read more
20 Nov 2020 08:34

Court denies GSK appeal in Vectura intellectual property dispute

(Sharecast News) - Inhalation-focussed contract design and manufacture organisation Vectura Group announced on Friday that the United States Court of Appeals for the Federal Circuit has denied GlaxoSmithKline's (GSK) motions for judgment as a matter of law, a new trial on infringement, and for a new trial on damages in litigation concerning Vectura's US patent 8303991.

Read more
19 Nov 2020 20:25

IN BRIEF: Vectura Notes US Court Denying GSK's Motions For New Trials

IN BRIEF: Vectura Notes US Court Denying GSK's Motions For New Trials

Read more
28 Sep 2020 15:53

UK EXECUTIVE CHANGE SUMMARY: Tracsis Appoints New Finance Chief

UK EXECUTIVE CHANGE SUMMARY: Tracsis Appoints New Finance Chief

Read more
22 Sep 2020 19:34

IN BRIEF: Vectura Notes Hikma's Advair US Regulatory Setback

IN BRIEF: Vectura Notes Hikma's Advair US Regulatory Setback

Read more
15 Sep 2020 17:22

Vectura Revenue Slips But Swings To First Half Profit

Vectura Revenue Slips But Swings To First Half Profit

Read more
14 Sep 2020 17:21

UK TRADING UPDATE SUMMARY: Henry Boot Unit In Voluntary Liquidation

UK TRADING UPDATE SUMMARY: Henry Boot Unit In Voluntary Liquidation

Read more
2 Sep 2020 19:36

TOP NEWS: ITV Bumped From FTSE 100 For B&M European Value Retail

TOP NEWS: ITV Bumped From FTSE 100 For B&M European Value Retail

Read more
7 Jul 2020 16:35

UK TRADING UPDATE SUMMARY: Retailer Sosandar In Quarterly Revenue Jump

UK TRADING UPDATE SUMMARY: Retailer Sosandar In Quarterly Revenue Jump

Read more
9 Jun 2020 12:04

DIRECTOR DEALINGS: Vectura Group Non-Exec Matthews Buys First Shares

DIRECTOR DEALINGS: Vectura Group Non-Exec Matthews Buys First Shares

Read more
8 Jun 2020 15:00

Vectura Inks Deal With Aerami To Develop Inhaled Imatinib

Vectura Inks Deal With Aerami To Develop Inhaled Imatinib

Read more

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.